All Stories

  1. B cell depletion in the treatment of multiple sclerosis

    Article • Expert Opinion on Biological Therapy, January 2019, Taylor & Francis

    Professor Øivind Torkildsen, Kjell-Morten Myhr

  2. Response to ‘Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients’, a comment letter regarding ‘Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients’

    Article • European Journal of Neurology, August 2018, Wiley

    Professor Øivind Torkildsen

  3. Glitazone use associated with reduced risk of Parkinson's disease

    Article • Movement Disorders, September 2017, Wiley

    Professor Øivind Torkildsen

  4. Disease‐modifying treatments for multiple sclerosis – a review of approved medications

    Article • European Journal of Neurology, November 2015, Wiley

    Professor Øivind Torkildsen

  5. Vitamin A, D and E and inflammation in RRMS

    Article • Journal of Neuroimmunology, June 2014, Elsevier

    Professor Øivind Torkildsen, Professor Kjell-Morten Myhr, Egil Røsjø

  6. Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments

    Article • Annals of Clinical and Translational Neurology, April 2014, Wiley

    Professor Øivind Torkildsen, Professor Kjell-Morten Myhr

  7. Month of birth and risk of multiple sclerosis: confounding and adjustments

    Article • Annals of Clinical and Translational Neurology, February 2014, Wiley

    Professor Øivind Torkildsen, Professor Kjell-Morten Myhr

  8. Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio in the Cuprizone Model

    Article • PLoS ONE, December 2013, PLOS

    Professor Øivind Torkildsen, Professor Kjell-Morten Myhr

  9. Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity

    Article • PLoS ONE, September 2013, PLOS

    Professor Øivind Torkildsen, Professor Kjell-Morten Myhr

  10. Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation

    Article • Nature Reports Stem Cells, April 2013, Springer Science + Business Media

    Professor Øivind Torkildsen

  11. No evidence of association between mutant alleles of theCYP27B1gene and multiple sclerosis

    Article • Annals of Neurology, February 2013, Wiley

    Professor Øivind Torkildsen, Professor Kjell-Morten Myhr